Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “I-131”

137 trials

Showing 20 of 137 results

Not applicableEnded earlyNCT00926978
What this trial is testing

Comparison of Iodine-124 (I-124) and Iodine-131 (I-131) Radiopharmacokinetics in Patients Prepared With Recombinant Human TSH Injection (rhTSH)

Who this might be right for
Thyroid Cancer
Medstar Health Research Institute 21
Testing effectiveness (Phase 2)Study completedNCT01573000
What this trial is testing

Study of Iodine-131 Anti-b1 Antibody Versus Anti-b1 Antibody in Chemotherapy-relapsed/Refractory Low-grade or Transformed Low-grade Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Lymphoma, Non-Hodgkin
GlaxoSmithKline 78
Early research (Phase 1)Ended earlyNCT01124812
What this trial is testing

131I-L19SIP Radioimmunotherapy Combined With Radiochemotherapy in Patients With Locally-advanced Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Philogen S.p.A. 3
Testing effectiveness (Phase 2)Study completedNCT00484874
What this trial is testing

Safety and Efficacy Study of I-131 Tositumomab in Patients With Relapsed/Refractory Hodgkin's Lymphoma

Who this might be right for
Hodgkin's Disease
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 12
Testing effectiveness (Phase 2)UnknownNCT00114309
What this trial is testing

131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeGBM+3 more
TransMolecular 66
Testing effectiveness (Phase 2)UnknownNCT00022932
What this trial is testing

Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade Non-Hodgkin's Lymphoma Following First Line CHOP

Who this might be right for
Non-Hodgkin's Lymphoma
Corixa Corporation
Testing effectiveness (Phase 2)Study completedNCT01868035
What this trial is testing

Iodine-131 Anti-B1 Antibody Consolidation for Patients With Non-Hodgkin's Lymphoma Following First-line CHOP

Who this might be right for
Lymphoma, Non-Hodgkin
GlaxoSmithKline 15
Not applicableEnded earlyNCT00342693
What this trial is testing

Thyroid Abnormalities Associated With Exposure to Atmospheric Emissions of Radioactive Iodine

Who this might be right for
Thyroid Abnormalities
National Cancer Institute (NCI) 360
Not applicableEnded earlyNCT02947399
What this trial is testing

Comparison of I-124 and I-131 Radiopharmacokinetics in DTC Patients With Thyroid Hormone Withdrawal

Who this might be right for
Thyroid Cancer
Medstar Health Research Institute 16
Large-scale testing (Phase 3)WithdrawnNCT00319332
What this trial is testing

A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic Regimen

Who this might be right for
Lymphoma, Small Cleaved-Cell, FollicularLymphoma, Large-Cell, FollicularLymphoma, Follicular+1 more
GlaxoSmithKline
Not applicableStudy completedNCT00416312
What this trial is testing

Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Testing effectiveness (Phase 2)Study completedNCT00107380
What this trial is testing

S0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 86
Early research (Phase 1)Study completedNCT00005978
What this trial is testing

N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
Testing effectiveness (Phase 2)Study completedNCT00251316
What this trial is testing

Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer

Who this might be right for
Thyroid CancerDifferentiated Thyroid Carcinoma
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 34
Large-scale testing (Phase 3)Study completedNCT00870558
What this trial is testing

Iodine I 131 Ethiodized Oil in Preventing Recurrent Cancer in Patients Who Have Undergone Treatment for Liver Cancer

Who this might be right for
Liver Cancer
Hospices Civils de Lyon 120
Not applicableStudy completedNCT01988272
What this trial is testing

Imaging Based Dosimetry for Individualized Internal Emitter Therapy

Who this might be right for
Non-Hodgkin's Lymphoma
University of Michigan 33
Early research (Phase 1)Active Not RecruitingNCT02914405
What this trial is testing

Phase I Study of 131-I mIBG Followed by Nivolumab & Dinutuximab Beta Antibodies in Children With Relapsed/Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
University Hospital Southampton NHS Foundation Trust 44
Testing effectiveness (Phase 2)Study completedNCT00022945
What this trial is testing

Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Corixa Corporation
Not applicableAvailableNCT01163383
What this trial is testing

131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access Protocol

Who this might be right for
NeuroblastomaChildhood Metastatic Pheochromocytoma
John Maris
Not applicableStudy completedNCT00223158
What this trial is testing

Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer

Who this might be right for
Thyroid Cancer
Patrice Perron 70
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation